Rufeng Ma

23 papers receiving 1.3k citations

Peers

Rufeng Ma
Comparison fields: 5 of 128
  • Complementary and alternative medicine 195
  • Pharmacology 202
  • Orthopedics and Sports Medicine 106
  • Biochemistry 64
  • Molecular Biology 657
Replace Fangfang Mo with:
Fangfang Mo China
Dandan Zhao China
Zhonglin Yang China
Longhuo Wu China
Ruyuan Zhu China
Yue Jin China
Quanlong Zhang China
Yunjo Soh South Korea
Weiying Guo China
Jin-Woo Jeong South Korea
Rufeng Ma relative to Fangfang Mo China Fangfang Mo's profile →
Citations per field
00.5×1.5×
Fangfang Mo · 1×
Citations per year

Countries citing papers authored by Rufeng Ma

Since Specialization
Citations

This map shows the geographic impact of Rufeng Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rufeng Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rufeng Ma more than expected).

Fields of papers citing papers by Rufeng Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rufeng Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rufeng Ma. The network helps show where Rufeng Ma may publish in the future.

Co-authors

The 25 scholars most cited alongside Rufeng Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rufeng Ma Line = papers co-authored together Rufeng Ma links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2017237
2 2016185
3 2017140
4 2017110
5 201588
6 201771
7 201759
8 201754
9 201650
10 201743
11 201739
12 201636
13 201833
14 202127
15 201821
16 201818
17 202014
18 202013
19 201911
20 202110

About Rufeng Ma

Rufeng Ma is a scholar working on Anatomy, Molecular Medicine, Pharmacology, Geriatrics and Gerontology and Molecular Biology, having authored 24 papers that have together received 1.3k indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (10 papers), Adipose Tissue and Metabolism (5 papers), Natural product bioactivities and synthesis (4 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers), Phytochemistry and Biological Activities (3 papers), Biomarkers in Disease Mechanisms (3 papers), Bone health and osteoporosis research (2 papers) and Natural Antidiabetic Agents Studies (2 papers). The work is most often cited by research in Complementary and alternative medicine (195 citations), Pharmacology (202 citations), Orthopedics and Sports Medicine (106 citations), Biochemistry (64 citations) and Molecular Biology (657 citations). Rufeng Ma has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Dongwei Zhang, Gao S, Ruyuan Zhu, Jianzhao Niu, Chenyue Liu, Min Fu, Beibei Chen, Min Fu, Yubo Guo and Lili Wang. Their work appears in journals such as Phytotherapy Research, Cellular Physiology and Biochemistry, BioMed Research International, Current Pharmaceutical Design and Frontiers in Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026